Skip to main content

$0.525 (0%)

High

$0.53

Low

$0.53

Trades

7

Turnover

$2,970

Volume

5,657
30 June 2023 at 12:06pm
Register to track GSS and receive email alerts.
Subject
GSS Ann: CFO/Company Secretary Appointment

GSS Ann: Quarterly update and Appendix 4C

GSS Ann: Company Secretary/CFO Appointment/Resignation

GSS Ann: Investor Presentation

GSS Ann: Change of Director's Interest Notice

GSS Ann: Half Yearly Report and Accounts

GSS Ann: Investor presentation

GSS Ann: Quarterly update and Appendix 4C

GSS Ann: Notification of cessation of securities - GSS

GSS Ann: Investor webinar presentation

GSS Ann: Change of Director's Interest Notice

GSS Ann: Notification regarding unquoted securities - GSS

GSS Ann: Results of Meeting

GSS Ann: Chairman's Address to Shareholders & CEO Presentation

GSS Ann: Change of Registry Address

GSS Ann: Notification regarding unquoted securities - GSS

GSS Ann: Notification of cessation of securities - GSS

GSS Ann: Application for quotation of securities - GSS

GSS Ann: Quarterly update and Appendix 4C

GSS Ann: Investor presentation

GSS Ann: Notice of Annual General Meeting/Proxy Form

GSS Ann: Response to ASX Query

GSS Ann: Appendix 4G and Corporate Governance Statement

GSS Ann: Annual Report to shareholders

GSS Ann: 3base Kit for Antimicrobial Resistance Shows High Detection

GSS Ann: Investor presentation

GSS Ann: Full Year Statutory Accounts

GSS Ann: Quarterly update and Appendix 4C

GSS Ann: Clinical trial recruitment completed for US enteric kit

GSS Ann: Notification of cessation of securities - GSS

GSS Ann: Application for quotation of securities - GSS

GSS Ann: Initial Director's Interest Notice

GSS Ann: Director Appointment

GSS Ann: Notification of cessation of securities - GSS

GSS Ann: Application for quotation of securities - GSS

GSS Ann: Investor presentation

GSS Ann: Quarterly update and Appendix 4C

GSS Ann: Application for quotation of securities - GSS

GSS Ann: Public Health Wales Awards Enteric Testing Contract to GSS

GSS Ann: S&P DJI Announces March 2022 Quarterly Rebalance

GSS Ann: Company presentation

GSS Ann: Half Yearly Report and Accounts

GSS Ann: Investor webinar presentation

GSS Ann: Application for quotation of securities - GSS

GSS Ann: Investor presentation

GSS Ann: Quarterly update and Appendix 4C

GSS Ann: Application for quotation of securities - GSS

GSS Ann: 3base SARS-CoV-2 kit registered by TGA for saliva samples

GSS Ann: Investor update

GSS Ann: Change of Director's Interest Notice

Register to track GSS and receive email alerts.

Similar Companies

ADO
BPH
CTE
GTG
MEM
OSL
PAL
PIQ